PPCB (Propanc Biopharma) Short-term investments


PPCB Propanc Biopharma Inc PPCB
29 GF Score
Price $1.62
! 2 Warning Signs
View Full Analysis

What is Propanc Biopharma Short-term investments?

Short-term investments only applies to insurance companies.

PPCB
29GF Score
Propanc Biopharma Inc PPCB
Short-term investments is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Propanc Biopharma Business Description

Address 302, 6 Butler Street, Cambwerwell, VIC, AUS, 3124
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.
29GF Score

Get the complete analysis for PPCB

Short-term investments is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.62
Price